Cite
MLA Citation
F Magro et al.. “Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.” Journal of Crohn's and colitis, vol. 13, 2019, pp. 1387–1393. http://access.bl.uk/ark:/81055/vdc_100094625064.0x00000e